206
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Is Bilateral Age-related Macular Degeneration Less Common in Asians than Caucasians?

, , , , , , & show all
Pages 253-258 | Received 17 Jun 2010, Accepted 17 Jun 2011, Published online: 04 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Raba Thapa, Sanyam Bajimaya, Govinda Paudyal, Shankar Khanal, Stevie Tan, Suman S Thapa & Ger van Rens. (2017) Prevalence of and risk factors for age-related macular degeneration in Nepal: the Bhaktapur Retina Study. Clinical Ophthalmology 11, pages 963-972.
Read now

Articles from other publishers (3)

Adrian H. C. Koh. 2020. Choroidal Neovascularization. Choroidal Neovascularization 217 236 .
Yuichiro Ogura, Hiroko Terasaki, Fumi Gomi, Mitsuko Yuzawa, Tomohiro Iida, Miki Honda, Koichi Nishijo, Olaf Sowade, Tetsushi Komori, Ursula Schmidt-Erfurth, Christian Simader & Victor Chong. (2015) Efficacy and safety of intravitreal aflibercept injection in wet age-related macular degeneration: outcomes in the Japanese subgroup of the VIEW 2 study. British Journal of Ophthalmology 99:1, pages 92-97.
Crossref
Donghyun WangKyung Seek ChoiSung Jin Lee. (2014) Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab. Korean Journal of Ophthalmology 28:1, pages 32.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.